Daehwa gets Canada patent for oral paclitaxel

Daehwa Pharm said on October 26 that it has recently won Canada patent covering the oral form of widely used cancer drug paclitaxel, which is normally administered through injection, following its patent acquisition in several countries, including China and Russia.

The patent covers "formulations and methods that make it possible to administer orally therapeutic agents such as paclitaxel and...